Why the study?
Does the modified Valsalva maneuver improve the success rate of cardioversion in patients with PSVT?
Does the modified Valsalva maneuver improve the success rate of cardioversion in patients with PSVT?
The modified Valsalva maneuver significantly improves cardioversion success rates in PSVT without increasing adverse reactions, supporting its use as a routine first-line treatment.
Supports first-line modified Valsalva in PSVT; confirms benefit without added risk in Level-1 meta-analysis.
Current evidence suggests that the modified Valsalva maneuver can significantly improve the success rate of cardioversion in patients with PSVT without increasing adverse reactions. The modified Valsalva maneuver is therefore worth promoting and should be considered as a routine first treatment.INPLASY registration number: 2023100092.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: